MedTech Dive August 19, 2024
Susan Kelly

Edwards, which has made a series of acquisitions in recent months, is also investing $25 million in Singapore-based Genesis Medtech.

Dive Brief:

  • Edwards Lifesciences has purchased a transcatheter aortic valve replacement (TAVR) system from Genesis Medtech that is designed to treat severe aortic regurgitation.
  • The sale of Genesis’ JC Medical business includes intellectual property and commercial rights for the J-Valve system. Edwards will pay an upfront sum and potential sales-based milestone payments. A sale price was not disclosed in Genesis’ Monday announcement.
  • Edwards has also made an equity investment of $25 million in Singapore-based Genesis to support product and market development efforts.

Dive Insight:

Edwards has been on an acquisition spree. In July, the heart valve specialist said...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Medical Devices, Mergers & Acquisitions / JV, Trends
Related Articles:
UN warns of military brain control
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry

Share This Article